There are 2137 resources available
857P - Long-term survival outcomes in endometrial cancer patients having lymphadenectomy, sentinel node mapping followed by backup lymphadectomy and sentinel node mapping alone: A multi-institutional Italian experience
Presenter: Giorgio Bogani
Session: E-Poster Display
Resources:
Abstract
858P - Patient-reported outcomes (PROs) in the GARNET trial in patients (pts) with advanced or recurrent mismatch repair deficient/microsatelite instability-high (dMMR/MSI-H) endometrial cancer (EC) treated with dostarlimab
Presenter: Rebecca Kristeleit
Session: E-Poster Display
Resources:
Abstract
859P - Impact of treatment modalities on quality of life for endometrial cancer patients in Norway
Presenter: David Forsse
Session: E-Poster Display
Resources:
Abstract
860P - Redefining prognosis in early-stage high-grade endometrial cancer
Presenter: Jorge Ramón
Session: E-Poster Display
Resources:
Abstract
861P - Limited implementation of the ESMO-ESGO (European Society of Gynaecological Oncology)-ESTRO (European Society for Radiotherapy and Oncology) consensus conference recommendations (CCR) on endometrial cancer (EC)
Presenter: Cristiana Sessa
Session: E-Poster Display
Resources:
Abstract
862P - Prognostic role of CD3, CD4, CD8 and FOXP3 positive populations in early-stage endometrial carcinoma
Presenter: Victoria Heredia Soto
Session: E-Poster Display
Resources:
Abstract
863P - A phase I study of mirvetuximab soravtansine (MIRV) and gemcitabine (G) in pts with selected FRα -positive solid tumours: Results in the endometrial cancer (EC) cohort
Presenter: Mihaela Cristea
Session: E-Poster Display
Resources:
Abstract
864P - Phase II of ABTL0812, a pro-autophagic drug, in combination with paclitaxel and carboplatin (P/C) as first-line treatment in advanced/recurrent endometrial cancer
Presenter: Alexandra Leary
Session: E-Poster Display
Resources:
Abstract
865P - A phase II study of sintilimab plus anlotinib for Chinese patients (pts) with persistent, recurrent, or metastatic cervical cancer (CC)
Presenter: Qin Xu
Session: E-Poster Display
Resources:
Abstract
866P - Neoadjuvant chemotherapy followed by radical surgery versus concurrent chemoradiotherapy in patients with stage IIA-IIIA cervical carcinoma
Presenter: Mingyang Yuan
Session: E-Poster Display
Resources:
Abstract